Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

IIT2020-02-Gong-GlutaPanc: Phase I Trial of First-line L-glutamine With Gemcitabine and Nab-paclitaxel in Advanced Pancreatic Cancer (GlutaPanc)

NCT04634539 is registered in ClinicalTrials.gov with Jun Gong, MD as lead sponsor.

NCT NCT04634539
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04634539 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
IIT2020-02-Gong-GlutaPanc: Phase I Trial of First-line L-glutamine With Gemcitabine and Nab-paclitaxel in Advanced Pancreatic Cancer (GlutaPanc)
Lead sponsor
Jun Gong, MD
Phase
Phase 1
Overall status
Completed
Start date
May 13, 2021
Completion date
June 17, 2025
Enrollment
18 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

advanced pancreatic adenocarcinoma, pancreatic cancer, pancreatic ductal adenocarcinoma